| Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ... Journal of extracellular vesicles 13 (2), e12404, 2024 | 997 | 2024 |
| Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis E Koh, EJ Lee, GH Nam, Y Hong, E Cho, Y Yang, IS Kim Biomaterials 121, 121-129, 2017 | 342 | 2017 |
| Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy GH Nam, Y Choi, GB Kim, S Kim, SA Kim, IS Kim Advanced Materials 32 (51), 2002440, 2020 | 232 | 2020 |
| Exosome as a vehicle for delivery of membrane protein therapeutics, PH20, for enhanced tumor penetration and antitumor efficacy Y Hong, GH Nam, E Koh, S Jeon, GB Kim, C Jeong, DH Kim, Y Yang, ... Advanced Functional Materials 28 (5), 1703074, 2018 | 136 | 2018 |
| Virus-Mimetic Fusogenic Exosomes for Direct Delivery of Integral Membrane Proteins to Target Cell Membranes. Y Yang, Y Hong, GH Nam, JH Chung, E Koh, IS Kim Advanced Materials (Deerfield Beach, Fla.) 29 (13), 2017 | 134 | 2017 |
| Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity S Yang, MK Shim, WJ Kim, J Choi, GH Nam, J Kim, J Kim, Y Moon, ... Biomaterials 272, 120791, 2021 | 113 | 2021 |
| Comparison of exosomes and ferritin protein nanocages for the delivery of membrane protein therapeutics E Cho, GH Nam, Y Hong, YK Kim, DH Kim, Y Yang, IS Kim Journal of Controlled Release 279, 326-335, 2018 | 108 | 2018 |
| Targeted delivery of anti-inflammatory cytokine by nanocarrier reduces atherosclerosis in Apo E−/-mice M Kim, A Sahu, Y Hwang, GB Kim, GH Nam, IS Kim, IC Kwon, G Tae Biomaterials 226, 119550, 2020 | 104 | 2020 |
| Programmed cell death protein ligand-1 silencing with polyethylenimine–dermatan sulfate complex for dual inhibition of melanoma growth G Kwak, D Kim, G Nam, SY Wang, IS Kim, SH Kim, IC Kwon, Y Yeo ACS nano 11 (10), 10135-10146, 2017 | 98 | 2017 |
| Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer GH Nam, EJ Lee, YK Kim, Y Hong, Y Choi, MJ Ryu, J Woo, Y Cho, DJ Ahn, ... Nature communications 9 (1), 2165, 2018 | 97 | 2018 |
| Harnessing designed nanoparticles: Current strategies and future perspectives in cancer immunotherapy SD Jo, GH Nam, G Kwak, Y Yang, IC Kwon Nano Today 17, 23-37, 2017 | 81 | 2017 |
| Nanocage‐therapeutics prevailing phagocytosis and immunogenic cell death awakens immunity against cancer EJ Lee, GH Nam, NK Lee, M Kih, E Koh, YK Kim, Y Hong, S Kim, SY Park, ... Advanced materials 30 (10), 1705581, 2018 | 75 | 2018 |
| Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis M Kim, A Sahu, GB Kim, GH Nam, W Um, SJ Shin, YY Jeong, IS Kim, ... Journal of Controlled Release 269, 337-346, 2018 | 75 | 2018 |
| Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer GH Nam, M Kwon, H Jung, E Ko, SA Kim, Y Choi, SJ Song, S Kim, Y Lee, ... Journal for ImmunoTherapy of Cancer 9 (7), 2021 | 56 | 2021 |
| In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic … S Kim, SA Kim, GH Nam, Y Hong, GB Kim, Y Choi, S Lee, Y Cho, M Kwon, ... Journal for ImmunoTherapy of Cancer 9 (1), 2021 | 56 | 2021 |
| Degradation of tumour stromal hyaluronan by small extracellular vesicle-PH20 stimulates CD103+ dendritic cells and in combination with PD-L1 blockade boosts … Y Hong, YK Kim, GB Kim, GH Nam, SA Kim, Y Park, Y Yang, IS Kim Journal of Extracellular Vesicles 8 (1), 1670893, 2019 | 55 | 2019 |
| Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity GB Kim, GH Nam, Y Hong, J Woo, Y Cho, IC Kwon, Y Yang, IS Kim Science Advances 6 (27), eaaz2083, 2020 | 54 | 2020 |
| The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy M Kwon, H Jung, GH Nam, IS Kim Journal of Controlled Release 331, 321-334, 2021 | 53 | 2021 |
| Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics NK Lee, EJ Lee, S Kim, G Nam, M Kih, Y Hong, C Jeong, Y Yang, Y Byun, ... Journal of Controlled Release 267, 172-180, 2017 | 50 | 2017 |
| Intrinsic cancer vaccination Y Yang, GH Nam, GB Kim, YK Kim, IS Kim Advanced Drug Delivery Reviews 151, 2-22, 2019 | 34 | 2019 |
In-San KimKorea Institute of Science and TechnologyVerified email at kist.re.kr